ETF Investing

How Our Current Asset Allocation Model Breaks Down Today

We've put together a series of charts comparing ETFs to us towards our current asset model's portfolio mix. Here's how the breakdown looks today... Read Article

2 Long-Term MLPs Ripe for Income Investors

There are roughly 25 MLP ETFs trading in the U.S. and it is accurate to say more than half of the MLP ETFs around today are successes, with over $25 billion in combined assets under management. Read Article

Bad Apples: AAPL Earnings Could Jolt These ETFs

Investors are showing concern over AAPL before earnings. These ETFs might be the most at risk if Apple disappoints. Read Article

3 Emerging Markets ETFs to Feast On … If You Dare

It takes a daring investor to get involved in emerging markets ETFs. Here are some emerging markets ETFs with solid results for risk-tolerant investors. Read Article

Why Jack Bogle’s 50/50 Portfolio Flunks This Test

Vanguard's Jack Bogle has made asset allocation changes inside his personal investment portfolio that ignores these two rules of investment. Read Article

Cover Your Behind: 3 Liquid Alternatives to Buy

Rising interest rates and low current income pulling you down? Liquid alternatives could be the answer. Here are 3 ETFs to buy. Read Article

3 Dead-End Fracking and Energy Stocks

Fracking companies were all the rage until last year, when energy stocks collapsed en masse. Now, the few that remain face a bleak future. Read Article

Why Preferred Stocks Are In The Sweet Spot Now (PFF, PGX)

For retired investors seeking a low volatility income stream, here's why it hasn't gotten much better than owning preferred stocks this year. Read Article

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI. Read Article

QQQ: Far More Than Just a Bundle of Tech Stocks

The PowerShares QQQ Trust (QQQ) is a unique ETF that can serve many roles in your portfolio. It just depends on what you're looking for. Read Article

S&P 500 Investors Get New Choice for Direct REIT Exposure (XLRE)

Real estate investment trusts have been buried inside the S&P 500 but have received a giant promotion as the SPDR has opened two REIT ETFs Read Article

The 3 Best ETFs to Buy After the Fed’s Rate Hike

The smart money will bet on higher stock prices after the Fed resumes its tightening. Here are three of the best ETFs to buy after the rate hike. Read Article

XLRE and XLFS: SPDR Unleashes 2 New Bruisers

Lowered fees & two new ETFs should make investors very happy. Here's a closer look at the changes from State Street. Read Article

Bet on a Bounce with These Biotech ETFs

Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain. Read Article

Taking Stock of International ETFs After the Sell-Off

With the rebound in October, is it time to get back into international ETFs? The answer to that may lie in your personal risk tolerance. Read Article

Top ETF Income Ideas for the Remainder of 2015

The search for income is always an interesting investment dynamic. Here are our best income picks for the remainder of the year. Read Article

ProShares’ New ETFs Offer No Real Reason to Buy

While they are trying to be passive, ProShares' new stable of ETFs still smell like active management. Read Article

3 Preferred Stock ETFs to Power Up a Portfolio

While the Fed dithers about raising interest rates, you can look to preferred-stock ETFs like PFF, VRP and PFXF. Read Article

Be Careful Before Loving Leveraged Biotech ETFs

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs. Read Article

All About Nothing: Stock ETFs Celebrate Zero Percent Rate Policy

Sector ETFs rocketed off recent intra-day lows as investors believed the Fed will not move soon to raise interest rates. Now what? Read Article